|
KR100463475B1
(ko)
|
1995-06-08 |
2005-06-22 |
로셰 디아그노스틱스 게엠베하 |
자기성피그먼트
|
|
DE19520398B4
(de)
|
1995-06-08 |
2009-04-16 |
Roche Diagnostics Gmbh |
Magnetisches Pigment
|
|
US6200757B1
(en)
*
|
1999-01-19 |
2001-03-13 |
Dade Behring Inc. |
Method for controlling the extension of an oligonucleotide
|
|
US6509157B1
(en)
*
|
1999-11-05 |
2003-01-21 |
Roche Molecular Systems, Inc |
3 blocked nucleic acid amplification primers
|
|
JP2003514383A
(ja)
|
1999-11-17 |
2003-04-15 |
ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
磁性ガラス粒子、それらの製造方法、及びそれらの使用
|
|
JP2003516765A
(ja)
|
1999-12-15 |
2003-05-20 |
ジェン−プローブ・インコーポレーテッド |
鳥型結核菌(Mycobacteriumavium)複合体種の検出のための方法および組成物
|
|
US6664081B2
(en)
*
|
1999-12-17 |
2003-12-16 |
Gen-Probe Incorporated |
Nucleic acid amplification and detection of mycobacterium species
|
|
AU781192B2
(en)
*
|
1999-12-17 |
2005-05-12 |
Biomerieux Sa |
Nucleic acid amplification and detection of mycobacterium species
|
|
US7205129B1
(en)
*
|
2000-02-28 |
2007-04-17 |
Qiagen Gmbh |
Method for reducing artifacts in nucleic acid amplification
|
|
WO2001075139A1
(en)
*
|
2000-04-03 |
2001-10-11 |
Biolink Partners, Inc. |
Reversible chemical modification of nucleic acids and improved method for nucleic acid hybridization
|
|
US6548251B1
(en)
*
|
2000-09-05 |
2003-04-15 |
Fidelity Systems, Inc. |
Inhibition of molecular and biological processes using modified oligonucleotides
|
|
US20020031777A1
(en)
*
|
2000-09-08 |
2002-03-14 |
Linda Starr-Spires |
Ultra yield amplification reaction
|
|
US9708358B2
(en)
|
2000-10-06 |
2017-07-18 |
The Trustees Of Columbia University In The City Of New York |
Massive parallel method for decoding DNA and RNA
|
|
US6664079B2
(en)
|
2000-10-06 |
2003-12-16 |
The Trustees Of Columbia University In The City Of New York |
Massive parallel method for decoding DNA and RNA
|
|
DE60115811T2
(de)
*
|
2000-10-25 |
2006-08-03 |
Roche Diagnostics Gmbh |
Amplifizierung unter Verwendung von modifizierten Primern
|
|
EP1373574A4
(de)
*
|
2001-03-30 |
2007-01-03 |
Ge Healthcare Bio Sciences Ab |
P450-einzelnukleotidpolymorphismus-biochipanalyse
|
|
RU2218414C2
(ru)
*
|
2001-05-04 |
2003-12-10 |
Институт молекулярной биологии им. В.А. Энгельгардта РАН |
Способ интеграции множественных полимеразных реакций амплификации с последующим анализом амплифицированных последовательностей непосредственно на биочипе
|
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
US7026121B1
(en)
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
WO2002101041A1
(en)
*
|
2001-06-12 |
2002-12-19 |
Takara Bio Inc. |
Method of amplifying nucleic acid and method of detecting nucleotide polymorphism with the use of nucleotide analog
|
|
WO2003020983A1
(en)
*
|
2001-08-30 |
2003-03-13 |
Virginia Commonwealth University |
Allele specific pcr for genotyping
|
|
US7297485B2
(en)
*
|
2001-10-15 |
2007-11-20 |
Qiagen Gmbh |
Method for nucleic acid amplification that results in low amplification bias
|
|
US6617137B2
(en)
|
2001-10-15 |
2003-09-09 |
Molecular Staging Inc. |
Method of amplifying whole genomes without subjecting the genome to denaturing conditions
|
|
US7211382B2
(en)
*
|
2002-04-09 |
2007-05-01 |
Orchid Cellmark Inc. |
Primer extension using modified nucleotides
|
|
JP4457001B2
(ja)
*
|
2002-05-31 |
2010-04-28 |
セクレタリー・デパートメント・オブ・アトミック・エナジー |
ドナー/アクセプター部分が相補鎖上となる標的核酸検出のmet/fretに基づく方法
|
|
US9487823B2
(en)
|
2002-12-20 |
2016-11-08 |
Qiagen Gmbh |
Nucleic acid amplification
|
|
US7955795B2
(en)
|
2003-06-06 |
2011-06-07 |
Qiagen Gmbh |
Method of whole genome amplification with reduced artifact production
|
|
RU2240350C1
(ru)
*
|
2003-03-11 |
2004-11-20 |
НИИ онкологии им. проф. Н.Н.Петрова Минздрава РФ |
Способ идентификации генных мутаций и полиморфизмов
|
|
BRPI0408967B8
(pt)
|
2003-03-31 |
2021-07-27 |
Hoffmann La Roche |
kit e métodos para detecção de um ácido nucléico de vários membros do sorogrupo do vírus da encefalite japonesa em uma amostra biológica sob condições de hibridização rigorosas
|
|
US7820030B2
(en)
|
2003-04-16 |
2010-10-26 |
Handylab, Inc. |
System and method for electrochemical detection of biological compounds
|
|
US7892745B2
(en)
|
2003-04-24 |
2011-02-22 |
Xdx, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US7517978B1
(en)
|
2004-04-14 |
2009-04-14 |
Applied Biosystems, Llc |
Modified oligonucleotides and applications thereof
|
|
US7408051B2
(en)
|
2004-04-14 |
2008-08-05 |
Applera Corporation |
Modified oligonucleotides and applications thereof
|
|
US7939251B2
(en)
|
2004-05-06 |
2011-05-10 |
Roche Molecular Systems, Inc. |
SENP1 as a marker for cancer
|
|
WO2006112818A2
(en)
*
|
2005-04-14 |
2006-10-26 |
Applera Corporation |
3' modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and applications thereof as primers or probes
|
|
US20090232771A1
(en)
|
2004-07-13 |
2009-09-17 |
Takeda Pharmaceutical Company Limited |
Method of controlling cell functions
|
|
WO2006029184A2
(en)
*
|
2004-09-08 |
2006-03-16 |
Expression Diagnostics, Inc. |
Genes useful for diagnosing and monitoring inflammation related disorders
|
|
EP1809765A2
(de)
*
|
2004-11-04 |
2007-07-25 |
Roche Diagnostics GmbH |
Klassifizierung von aml (akuter myeloider leukämie)
|
|
US7842794B2
(en)
|
2004-12-17 |
2010-11-30 |
Roche Molecular Systems, Inc. |
Reagents and methods for detecting Neisseria gonorrhoeae
|
|
RU2299240C2
(ru)
*
|
2005-02-21 |
2007-05-20 |
Рамиль Ришадович Вафин |
Способ проведения пцр
|
|
US8067208B2
(en)
|
2005-06-30 |
2011-11-29 |
Roche Molecular Systems, Inc. |
Probes and methods for hepatitis C virus typing using multidimensional probe analysis
|
|
US11111543B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US11111544B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US10083273B2
(en)
|
2005-07-29 |
2018-09-25 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US9424392B2
(en)
|
2005-11-26 |
2016-08-23 |
Natera, Inc. |
System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
|
|
US10081839B2
(en)
|
2005-07-29 |
2018-09-25 |
Natera, Inc |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
WO2007139723A1
(en)
|
2006-06-01 |
2007-12-06 |
Trilink Biotechnologies |
Chemicallymodified oligonucleotide primers for nucleic acid amplification
|
|
WO2007147110A2
(en)
*
|
2006-06-16 |
2007-12-21 |
Pacific Biosciences Of California, Inc. |
Controlled initiation of primer extension
|
|
US9045522B2
(en)
|
2006-07-31 |
2015-06-02 |
Wanli Bi |
Nucleic acid amplification using a reversibly modified oligonucleotide
|
|
ATE538216T1
(de)
*
|
2006-07-31 |
2012-01-15 |
Wanli Bi |
Nukleinsäureverstärkung mithilfe eines reversibel modifizierten oligonukleotids
|
|
US7993832B2
(en)
|
2006-08-14 |
2011-08-09 |
Xdx, Inc. |
Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
|
|
EP2102367A2
(de)
|
2006-11-09 |
2009-09-23 |
XDX, Inc. |
Verfahren zur diagnose und überwachung des status von systemischem lupus erythematodes
|
|
US7883869B2
(en)
|
2006-12-01 |
2011-02-08 |
The Trustees Of Columbia University In The City Of New York |
Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
|
|
US7893227B2
(en)
|
2006-12-05 |
2011-02-22 |
Lasergen, Inc. |
3′-OH unblocked nucleotides and nucleosides base modified with non-cleavable, terminating groups and methods for their use in DNA sequencing
|
|
US7897737B2
(en)
|
2006-12-05 |
2011-03-01 |
Lasergen, Inc. |
3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
|
|
US9938641B2
(en)
|
2006-12-18 |
2018-04-10 |
Fluidigm Corporation |
Selection of aptamers based on geometry
|
|
ES2725003T3
(es)
*
|
2007-03-28 |
2019-09-18 |
Signal Diagnostics |
Sistema y método de análisis de alta resolución de ácidos nucleicos para detectar variaciones de secuencia
|
|
AU2008272421B2
(en)
|
2007-07-03 |
2014-09-04 |
Genaphora Ltd. |
Chimeric primers for improved nucleic acid amplification reactions
|
|
EP2952588A1
(de)
|
2007-08-06 |
2015-12-09 |
Orion Genomics, LLC |
Einzelnukleotid-polymorphismen zur bestimmung der allelspezifischen expression des igf2-gens
|
|
CA2639416C
(en)
|
2007-09-11 |
2019-12-31 |
F. Hoffmann-La Roche Ag |
Diagnostic test for susceptibility to b-raf kinase inhibitors
|
|
CN101889096B
(zh)
*
|
2007-10-04 |
2015-10-21 |
联邦科学及工业研究组织 |
核酸扩增
|
|
US20100086914A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Roche Molecular Systems, Inc. |
High resolution, high throughput hla genotyping by clonal sequencing
|
|
EP3431615A3
(de)
|
2007-10-19 |
2019-02-20 |
The Trustees of Columbia University in the City of New York |
Dna-sequenzierung mit nichtfluoreszierenden, reversiblen nukleotidterminatoren und spaltbaren, etikettmodifizierten nukleotidterminatoren
|
|
WO2009051807A1
(en)
|
2007-10-19 |
2009-04-23 |
The Trustees Of Columbia University In The City Of New York |
Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis
|
|
DE102008005667A1
(de)
|
2008-01-19 |
2009-07-30 |
Olfert Landt |
Basenmodifizierte Primeroligomere für die Multiplex-RT-PCR
|
|
US9434988B2
(en)
|
2008-04-30 |
2016-09-06 |
Integrated Dna Technologies, Inc. |
RNase H-based assays utilizing modified RNA monomers
|
|
US8911948B2
(en)
*
|
2008-04-30 |
2014-12-16 |
Integrated Dna Technologies, Inc. |
RNase H-based assays utilizing modified RNA monomers
|
|
DK2644707T3
(en)
|
2008-04-30 |
2015-06-29 |
Integrated Dna Tech Inc |
RNase-H-based assays using modified RNA monomers.
|
|
EA201100001A3
(ru)
|
2008-06-11 |
2013-03-29 |
Лейзеджен, Инк. |
Нуклеотиды и нуклеозиды и методы их использования в секвенировании днк
|
|
CN104732118B
(zh)
|
2008-08-04 |
2017-08-22 |
纳特拉公司 |
等位基因调用和倍性调用的方法
|
|
EP2337865B1
(de)
*
|
2008-10-20 |
2014-11-19 |
Roche Diagnostics GmbH |
Allelspezifische amplifikation, die einen primer mit modifiziertem nukleotid verwendet
|
|
US10669574B2
(en)
|
2008-11-18 |
2020-06-02 |
XCR Diagnostics, Inc. |
DNA amplification technology
|
|
US8206929B2
(en)
*
|
2009-01-07 |
2012-06-26 |
Roche Molecular Systems, Inc. |
Nucleic acid amplification with allele-specific suppression of sequence variants
|
|
EP2955234A1
(de)
|
2009-02-11 |
2015-12-16 |
Orion Genomics, LLC |
Kombinationen aus polymorphismen zur bestimmung von allelspezifischer expression von igf2
|
|
US8409802B2
(en)
|
2009-08-14 |
2013-04-02 |
Roche Molecular Systems, Inc. |
Format of probes to detect nucleic acid differences
|
|
ES2640776T3
(es)
|
2009-09-30 |
2017-11-06 |
Natera, Inc. |
Métodos para denominar de forma no invasiva ploidía prenatal
|
|
US9238832B2
(en)
*
|
2009-12-11 |
2016-01-19 |
Roche Molecular Systems, Inc. |
Allele-specific amplification of nucleic acids
|
|
US8614071B2
(en)
|
2009-12-11 |
2013-12-24 |
Roche Molecular Systems, Inc. |
Preferential amplification of mRNA over DNA using chemically modified primers
|
|
WO2011128096A1
(en)
|
2010-04-16 |
2011-10-20 |
Roche Diagnostics Gmbh |
Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
|
AU2011255641A1
(en)
|
2010-05-18 |
2012-12-06 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US20190010543A1
(en)
|
2010-05-18 |
2019-01-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11332785B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11322224B2
(en)
|
2010-05-18 |
2022-05-03 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US12221653B2
(en)
|
2010-05-18 |
2025-02-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11326208B2
(en)
|
2010-05-18 |
2022-05-10 |
Natera, Inc. |
Methods for nested PCR amplification of cell-free DNA
|
|
US11939634B2
(en)
|
2010-05-18 |
2024-03-26 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US9677118B2
(en)
|
2014-04-21 |
2017-06-13 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11332793B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11339429B2
(en)
|
2010-05-18 |
2022-05-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11408031B2
(en)
|
2010-05-18 |
2022-08-09 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
|
US12152275B2
(en)
|
2010-05-18 |
2024-11-26 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US10316362B2
(en)
|
2010-05-18 |
2019-06-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US10179937B2
(en)
|
2014-04-21 |
2019-01-15 |
Natera, Inc. |
Detecting mutations and ploidy in chromosomal segments
|
|
WO2011153254A2
(en)
|
2010-06-04 |
2011-12-08 |
Chronix Biomedical |
Prostate cancer associated circulating nucleic acid biomarkers
|
|
WO2012038049A2
(en)
|
2010-09-22 |
2012-03-29 |
Roche Diagnostics Gmbh |
Amplification of distant nucleic acid targets using engineered primers
|
|
WO2012075005A1
(en)
|
2010-12-01 |
2012-06-07 |
Berry & Associates, Inc. |
Compounds for the synthetic introduction of n-alkyl nucleosides into dna oligonucleotides
|
|
US20120164641A1
(en)
*
|
2010-12-22 |
2012-06-28 |
Roche Molecular Systems, Inc. |
Methods and Compositions for Detecting Mutation in the Human Epidermal Growth Factor Receptor Gene
|
|
CA2821906C
(en)
|
2010-12-22 |
2020-08-25 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
|
CA2824387C
(en)
|
2011-02-09 |
2019-09-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US9624539B2
(en)
|
2011-05-23 |
2017-04-18 |
The Trustees Of Columbia University In The City Of New York |
DNA sequencing by synthesis using Raman and infrared spectroscopy detection
|
|
US9034581B2
(en)
|
2011-05-26 |
2015-05-19 |
Roche Molecular Systems, Inc. |
Compositions and methods for detection of Staphylococcus aureus
|
|
CA2852098C
(en)
|
2011-10-21 |
2023-05-02 |
Chronix Biomedical |
Colorectal cancer associated circulating nucleic acid biomarkers
|
|
ES2413566B1
(es)
|
2011-12-14 |
2014-05-20 |
Fundación Pública Andaluza Progreso Y Salud |
Método de obtención de datos útiles para el diagnóstico y pronóstico de la hipoacusia neurosensorial.
|
|
US9115394B2
(en)
|
2011-12-22 |
2015-08-25 |
Roche Molecular Systems, Inc. |
Methods and reagents for reducing non-specific amplification
|
|
KR101545848B1
(ko)
*
|
2012-04-09 |
2015-08-21 |
(주)바이오니아 |
핵산중합효소로 핵산을 검출하는데 사용되는 고민감도 핵산준비방법
|
|
EP2861757B1
(de)
|
2012-06-14 |
2019-11-06 |
Life Technologies Corporation |
Neuartige zusammensetzungen, verfahren und kits für polymerasekettenreaktionen (pcr)
|
|
US9982313B2
(en)
|
2012-08-17 |
2018-05-29 |
Roche Molecular Systems, Inc. |
Compositions and methods for detection of herpes simplex virus 1 and 2
|
|
US20140100126A1
(en)
|
2012-08-17 |
2014-04-10 |
Natera, Inc. |
Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
|
|
EP2722399A1
(de)
|
2012-10-18 |
2014-04-23 |
Roche Diagniostics GmbH |
Verfahren zur Vermeidung von Produkten mit hohem Molekulargewicht während einer Amplifikation
|
|
US9382581B2
(en)
|
2012-12-13 |
2016-07-05 |
Roche Molecular Systems, Inc. |
Primers with modified phosphate and base in allele-specific PCR
|
|
EP2931922B1
(de)
|
2012-12-14 |
2018-10-17 |
Chronix Biomedical |
Personalisierte biomarker für krebs
|
|
US10648026B2
(en)
|
2013-03-15 |
2020-05-12 |
The Trustees Of Columbia University In The City Of New York |
Raman cluster tagged molecules for biological imaging
|
|
US9828629B2
(en)
|
2013-03-15 |
2017-11-28 |
Roche Molecular Systems, Inc. |
Nucleic acid target identification by structure based probe cleavage
|
|
LT3004388T
(lt)
|
2013-05-29 |
2019-01-25 |
Chronix Biomedical |
Donoro ne ląstelinės dnr aptikimas ir jos kiekio nustatymas organo transplantanto recipientų apytakoje
|
|
CA2920666A1
(en)
|
2013-08-12 |
2015-02-19 |
Genentech, Inc. |
Compositions and method for treating complement-associated conditions
|
|
US10262755B2
(en)
|
2014-04-21 |
2019-04-16 |
Natera, Inc. |
Detecting cancer mutations and aneuploidy in chromosomal segments
|
|
WO2015048535A1
(en)
|
2013-09-27 |
2015-04-02 |
Natera, Inc. |
Prenatal diagnostic resting standards
|
|
US10577655B2
(en)
|
2013-09-27 |
2020-03-03 |
Natera, Inc. |
Cell free DNA diagnostic testing standards
|
|
WO2015052147A1
(en)
|
2013-10-09 |
2015-04-16 |
Roche Diagnostics Gmbh |
Methods and compositions for detecting mutation in the human ezh2 gene
|
|
US10370707B2
(en)
|
2013-10-09 |
2019-08-06 |
Fluoresentric, Inc. |
Multiplex probes
|
|
JP2016538882A
(ja)
|
2013-10-30 |
2016-12-15 |
グリーン ライフ バイオテック,エルエルシー |
カンキツグリーニング病のための病因定量システム及び治療方法
|
|
US10072288B2
(en)
|
2013-11-11 |
2018-09-11 |
Roche Molecular Systems, Inc. |
Detecting single nucleotide polymorphism using overlapped primer and melting probe
|
|
US9637791B2
(en)
|
2013-12-20 |
2017-05-02 |
Roche Molecular Systems, Inc. |
Multiplexed nucleic acid target identification by strucutre based probe cleavage
|
|
TWI769970B
(zh)
|
2014-02-08 |
2022-07-11 |
美商建南德克公司 |
治療阿茲海默症之方法
|
|
US20180173846A1
(en)
|
2014-06-05 |
2018-06-21 |
Natera, Inc. |
Systems and Methods for Detection of Aneuploidy
|
|
HRP20200764T1
(hr)
|
2014-10-01 |
2020-07-24 |
Chronix Biomedical |
Metode za kvantifikaciju cirkulirajuće slobodne dnk
|
|
US9745618B2
(en)
|
2014-11-19 |
2017-08-29 |
Roche Molecular Systems, Inc. |
Photoblocked probes and methods for sequential detection of nucleic acids
|
|
US9920381B2
(en)
|
2014-12-02 |
2018-03-20 |
Roche Molecular Systems, Inc. |
Compositions and methods for detecting MECC-containing methicillin-resistant Staphylococcus aureus
|
|
US9909169B2
(en)
|
2014-12-17 |
2018-03-06 |
Roche Molecular Systems, Inc. |
Allele-specific amplification of nucleic acids using blocking oligonucleotides for wild type suppression
|
|
WO2016100049A1
(en)
|
2014-12-18 |
2016-06-23 |
Edico Genome Corporation |
Chemically-sensitive field effect transistor
|
|
US9859394B2
(en)
|
2014-12-18 |
2018-01-02 |
Agilome, Inc. |
Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
|
|
US9618474B2
(en)
|
2014-12-18 |
2017-04-11 |
Edico Genome, Inc. |
Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
|
|
US9857328B2
(en)
|
2014-12-18 |
2018-01-02 |
Agilome, Inc. |
Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
|
|
US10020300B2
(en)
|
2014-12-18 |
2018-07-10 |
Agilome, Inc. |
Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
|
|
US10006910B2
(en)
|
2014-12-18 |
2018-06-26 |
Agilome, Inc. |
Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
|
|
CN107849603B
(zh)
|
2015-04-24 |
2022-01-28 |
阿提拉生物系统公司 |
利用有限核苷酸组成的引物扩增
|
|
DK3294906T3
(en)
|
2015-05-11 |
2024-08-05 |
Natera Inc |
Methods for determining ploidy
|
|
US9970062B2
(en)
*
|
2015-08-06 |
2018-05-15 |
Roche Molecular Systems, Inc. |
Compositions and methods for detection of mycobacterium tuberculosis
|
|
US9382582B1
(en)
*
|
2015-08-25 |
2016-07-05 |
Tracy Hayden |
Methods, compositions and kits for enriching for a minor template amplification product in a mixed template amplification reaction
|
|
EP3402880B1
(de)
|
2016-01-15 |
2024-01-03 |
Thermo Fisher Scientific Baltics UAB |
Thermophile dna-polymerase-mutanten
|
|
CA3017265C
(en)
|
2016-03-11 |
2022-08-16 |
F. Hoffmann-La Roche Ag |
Compositions and methods for detection of zika virus
|
|
JP6681804B2
(ja)
*
|
2016-03-30 |
2020-04-15 |
大研医器株式会社 |
変異プライマーの設計方法
|
|
WO2017169119A1
(ja)
*
|
2016-03-30 |
2017-10-05 |
大研医器株式会社 |
変異プライマーの設計方法
|
|
WO2017181202A2
(en)
|
2016-04-15 |
2017-10-19 |
Natera, Inc. |
Methods for lung cancer detection
|
|
WO2017201081A1
(en)
|
2016-05-16 |
2017-11-23 |
Agilome, Inc. |
Graphene fet devices, systems, and methods of using the same for sequencing nucleic acids
|
|
US10612101B2
(en)
*
|
2016-05-27 |
2020-04-07 |
Roche Molecular Systems, Inc. |
Compositions and methods for detection of Mycoplasma genitalium
|
|
EP3464617B1
(de)
|
2016-05-27 |
2021-04-07 |
Roche Diagnostics GmbH |
Zusammensetzungen und verfahren zur detektion von trichomonas vaginalis
|
|
US10934597B2
(en)
*
|
2016-05-27 |
2021-03-02 |
Roche Molecular Systems, Inc. |
Compositions and methods for detection of trichomonas vaginalis
|
|
US20170356025A1
(en)
|
2016-06-14 |
2017-12-14 |
Roche Molecular Systems, Inc. |
Internal control probes for improving pcr assay performance
|
|
US10443095B2
(en)
|
2016-08-02 |
2019-10-15 |
Roche Molecular Systems, Inc. |
Helper oligonucleotide for improved efficiency of amplification and detection/quantitation of nucleic acids
|
|
WO2018067517A1
(en)
|
2016-10-04 |
2018-04-12 |
Natera, Inc. |
Methods for characterizing copy number variation using proximity-litigation sequencing
|
|
GB201618485D0
(en)
|
2016-11-02 |
2016-12-14 |
Ucl Business Plc |
Method of detecting tumour recurrence
|
|
US10793923B2
(en)
|
2016-11-09 |
2020-10-06 |
Roche Molecular Systems, Inc. |
Compositions and methods for detection of BK virus
|
|
US12275999B2
(en)
|
2016-11-10 |
2025-04-15 |
Talis Biomedical Corporation |
Polynucleotides for the amplification and detection of chlamydia trachomatis
|
|
WO2018089945A1
(en)
|
2016-11-10 |
2018-05-17 |
Slipchip Corporation |
Polynucleotides for the amplification and detection of neisseria gonorrhoeae
|
|
US10011870B2
(en)
|
2016-12-07 |
2018-07-03 |
Natera, Inc. |
Compositions and methods for identifying nucleic acid molecules
|
|
US20190211377A1
(en)
|
2016-12-22 |
2019-07-11 |
Roche Molecular Systems, Inc. |
Cobra probes to detect a marker for epidemic ribotypes of clostridium difficile
|
|
EP3585889A1
(de)
|
2017-02-21 |
2020-01-01 |
Natera, Inc. |
Zusammensetzungen, verfahren und kits zur isolierung von nukleinsäuren
|
|
EP3645710A1
(de)
|
2017-06-26 |
2020-05-06 |
Thermo Fisher Scientific Baltics Uab |
Thermophile dna-polymerase-mutanten
|
|
US10760137B2
(en)
|
2017-07-18 |
2020-09-01 |
Roche Molecular Systems, Inc. |
Compositions and methods for detection of Babesia
|
|
US11591645B2
(en)
*
|
2017-08-31 |
2023-02-28 |
Seegene, Inc. |
Evaluation of performance of components using a pair of dimer-forming primers
|
|
WO2019063661A1
(en)
|
2017-09-29 |
2019-04-04 |
Roche Diagnostics Gmbh |
COMPOSITIONS AND METHODS FOR THE DETECTION OF TRICHOMONAS VAGINALIS
|
|
CA3085933A1
(en)
|
2017-12-14 |
2019-06-20 |
Tai Diagnostics, Inc. |
Assessing graft suitability for transplantation
|
|
WO2019161244A1
(en)
|
2018-02-15 |
2019-08-22 |
Natera, Inc. |
Methods for isolating nucleic acids with size selection
|
|
EP3768832B1
(de)
|
2018-03-21 |
2023-11-29 |
F. Hoffmann-La Roche AG |
Dna-polymerasen zum effizienten und effektiven einbau von methylierten dntps
|
|
EP3781714B1
(de)
|
2018-04-14 |
2026-01-07 |
Natera, Inc. |
Verfahren zur krebserkennung und -überwachung durch personalisierte detektion zirkulierender tumor-dna
|
|
US10450616B1
(en)
|
2018-05-09 |
2019-10-22 |
Talis Biomedical Corporation |
Polynucleotides for the amplification and detection of Chlamydia trachomatis
|
|
WO2020006421A1
(en)
|
2018-06-29 |
2020-01-02 |
Pacific Biosciences Of California, Inc. |
Methods and compositions for delivery of molecules and complexes to reaction sites
|
|
US12234509B2
(en)
|
2018-07-03 |
2025-02-25 |
Natera, Inc. |
Methods for detection of donor-derived cell-free DNA
|
|
CN113227398B
(zh)
*
|
2018-10-29 |
2025-03-14 |
塞弗德公司 |
在减少的扩增时间下使用巢式重叠引物的指数基数-3核酸扩增
|
|
ES3031673T3
(en)
|
2018-12-03 |
2025-07-10 |
Hoffmann La Roche |
Compositions and methods for detection of candida auris
|
|
WO2020132279A1
(en)
|
2018-12-19 |
2020-06-25 |
Nuclein, Llc |
Apparatus and methods for molecular diagnostics
|
|
KR102141312B1
(ko)
*
|
2019-04-19 |
2020-08-04 |
주식회사 제노헬릭스 |
짧은 RNA-primed 제노 센서 모듈 증폭 기반 짧은 RNA 탐지 기법
|
|
JP7628085B2
(ja)
|
2019-05-02 |
2025-02-07 |
エフ. ホフマン-ラ ロシュ アーゲー |
鎖分離温度に基づくDNAに対してRNA標的の優先的/選択的増幅のためのdITPの利用
|
|
CN113795596A
(zh)
|
2019-05-07 |
2021-12-14 |
豪夫迈·罗氏有限公司 |
用于检测淋病奈瑟氏球菌的组合物和方法
|
|
US12305235B2
(en)
|
2019-06-06 |
2025-05-20 |
Natera, Inc. |
Methods for detecting immune cell DNA and monitoring immune system
|
|
US10954572B2
(en)
|
2019-07-25 |
2021-03-23 |
Talis Biomedical Corporation |
Polynucleotides for the amplification and detection of Neisseria gonorrhoeae
|
|
JP7649285B2
(ja)
|
2019-07-25 |
2025-03-19 |
エフ. ホフマン-ラ ロシュ アーゲー |
エプスタイン・バーウイルス(ebv)を検出するための組成物および方法
|
|
US11739382B2
(en)
|
2019-08-27 |
2023-08-29 |
Roche Molecular Systems, Inc. |
Compositions and methods for amplification and detection of hepatitis B virus RNA, including HBV RNA transcribed from cccDNA
|
|
US11441167B2
(en)
|
2019-11-20 |
2022-09-13 |
Roche Molecular Systems, Inc. |
Compositions and methods for rapid identification and phenotypic antimicrobial susceptibility testing of bacteria and fungi
|
|
US11891662B2
(en)
|
2019-12-02 |
2024-02-06 |
Talis Biomedical Corporation |
Polynucleotides for amplification and detection of human beta actin
|
|
CN114867871A
(zh)
|
2019-12-27 |
2022-08-05 |
豪夫迈·罗氏有限公司 |
用于检测耐甲氧西林金黄色葡萄球菌的组合物和方法
|
|
US20220356537A1
(en)
|
2019-12-31 |
2022-11-10 |
Roche Molecular Systems, Inc. |
Quantitative pcr screening of inducible prophage from bacterial isolates
|
|
JP7796660B2
(ja)
|
2020-03-09 |
2026-01-09 |
エフ. ホフマン-ラ ロシュ アーゲー |
重症急性呼吸器症候群コロナウイルス2(sars-cov-2)、インフルエンザa及びインフルエンザbを検出するための組成物及び方法
|
|
US12264365B2
(en)
|
2020-03-23 |
2025-04-01 |
Talis Biomedical Corporation |
Polynucleotides for amplification and detection of SARS-CoV-2
|
|
WO2022029157A2
(en)
|
2020-08-06 |
2022-02-10 |
F. Hoffmann-La Roche Ag |
Compositions and methods for the detection of severe acute respiratory syndrome coronavirus 2 (sars-2), influenza a, and influenza b
|
|
EP4256089A1
(de)
|
2020-12-04 |
2023-10-11 |
F. Hoffmann-La Roche AG |
Zusammensetzungen und verfahren zum nachweis von malaria
|
|
US20220205020A1
(en)
|
2020-12-30 |
2022-06-30 |
Roche Molecular Systems, Inc. |
Compositions and methods for detection of bacteria and fungi associated with bacterial and candida vaginosis
|
|
EP4288567A1
(de)
|
2021-02-05 |
2023-12-13 |
F. Hoffmann-La Roche AG |
Zusammensetzungen und verfahren zum nachweis des menschlichen parainfluenzavirus 1-4- (hpiv1-4)
|
|
US20220290221A1
(en)
*
|
2021-03-15 |
2022-09-15 |
Roche Molecular Systems, Inc. |
Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2) variants having spike protein mutations
|
|
CN117858960A
(zh)
|
2021-05-06 |
2024-04-09 |
豪夫迈·罗氏有限公司 |
用于通过双靶标测定来检测丁型肝炎病毒的组合物和方法
|
|
EP4426865A1
(de)
|
2021-11-05 |
2024-09-11 |
F. Hoffmann-La Roche AG |
Zusammensetzungen und verfahren zum nachweis von malaria
|
|
WO2023089186A1
(en)
|
2021-11-22 |
2023-05-25 |
F. Hoffmann-La Roche Ag |
Compositions and methods for detecting vana and/or vanb genes associated with multidrug resistance
|
|
EP4444904A1
(de)
|
2021-12-09 |
2024-10-16 |
F. Hoffmann-La Roche AG |
Massenbasierter nachweis von pcr-amplikons
|
|
WO2023109887A1
(zh)
|
2021-12-15 |
2023-06-22 |
南京金斯瑞生物科技有限公司 |
一种整合位点的检测方法
|
|
JP2025521750A
(ja)
|
2022-06-30 |
2025-07-10 |
エフ. ホフマン-ラ ロシュ アーゲー |
クラミジア・トラコマチス(chlamydia trachomatis)の鼠径リンパ肉芽腫症(lgv)血清型を検出するための組成物および方法
|
|
EP4558648A1
(de)
*
|
2022-07-18 |
2025-05-28 |
Haystackanalytics Private Limited |
Verfahren und systeme zum nachweis und zur identifizierung von pathogenen und antibiotikaresistenzgenen
|
|
EP4577674A1
(de)
|
2022-08-24 |
2025-07-02 |
F. Hoffmann-La Roche AG |
Zusammensetzungen und verfahren zum nachweis des affektoxvirus
|
|
JP2025542121A
(ja)
|
2022-12-25 |
2025-12-25 |
エフ. ホフマン-ラ ロシュ アーゲー |
カルバペネム耐性アシネトバクター・カルコアセチカス-バウマンニ(acinetobacter calcoaceticus-baumannii)(crab)を検出するための組成物および方法
|
|
EP4642924A1
(de)
|
2022-12-28 |
2025-11-05 |
F. Hoffmann-La Roche AG |
Digitale pcr-testdesigns für mehrere hepatitis-b-virus-genziele und nicht-dehnbare blockeroligonukleotide dafür
|
|
EP4669777A1
(de)
|
2023-02-25 |
2025-12-31 |
F. Hoffmann-La Roche AG |
Zusammensetzungen und verfahren zum nachweis von candida-spezies
|
|
WO2024184165A1
(en)
|
2023-03-03 |
2024-09-12 |
F. Hoffmann-La Roche Ag |
Compositions and methods for the detection of group b streptococcus ( streptococcus agalactiae) and clindamycin resistance gene determinants
|
|
WO2025024676A1
(en)
|
2023-07-26 |
2025-01-30 |
Caribou Biosciences, Inc. |
In vitro validation methods for cd19-targeting cell therapies
|
|
WO2025027080A1
(en)
|
2023-08-03 |
2025-02-06 |
F. Hoffmann-La Roche Ag |
Use of 5'-tailed long primers to improve amplification performance when targeting short primer-binding sites
|
|
WO2025202488A1
(en)
|
2024-03-28 |
2025-10-02 |
Roche Diagnostics Gmbh |
Enhancer of nucleic acid amplification
|
|
WO2026052826A1
(en)
|
2024-09-09 |
2026-03-12 |
Roche Diagnostics Gmbh |
Methods for producing fluorescent dyes
|